Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(17/week)
Canada
(12/week)
Haiti
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
View all
(29/week)
News
United States
(1301/week)
Manufacturing
(724/week)
Energy
(519/week)
Technology
(1265/week)
Other Manufacturing
(494/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Brilacidin
Aug 28, 2019
Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer
Aug 15, 2019
Soligenix Announces $150,000 NIH Small Business Innovation Research Award Supporting Evaluation of SGX942 in Pediatric Indications
Apr 18, 2019
Soligenix Achieves Significant Enrollment Milestone for its Pivotal Phase 3 Clinical Trial of SGX942 in the Treatment of Oral Mucositis in Head and Neck Cancer
Apr 09, 2019
Soligenix and the European Medicines Agency Pediatric Committee Reach Agreement on the Pediatric Investigation Plan for SGX942
Apr 04, 2019
Soligenix Receives US Patent for Dusquetide Related Analogs
Mar 18, 2019
Soligenix to Present at National Institutes of Health - Commercialization Accelerator Program "FeedForward Session" in Washington, DC
Jan 23, 2019
Soligenix Receives European Patent for Dusquetide and Related Innate Defense Regulator Analogs
Oct 31, 2018
Global Oral Mucositis (OM) Market Insights, Epidemiology and Market Forecast to 2027: Focus on United States, EU5 (Germany, Spain, Italy, France and United Kingdom), Japan and China
Jul 19, 2018
Soligenix - Driving Towards Key Inflection Points with Two Pivotal Phase 3 Clinical Trials
Jun 04, 2018
Soligenix Announces Poster at the 2018 American Society of Microbiology Microbe Conference in Atlanta, Georgia
Jan 25, 2018
Prokaryotics Announces Licensing Agreement with Merck for Novel Investigational Antibiotic Candidates
Jan 02, 2018
Soligenix Announces US Patent Issuance for Use of Dusquetide in Oral Mucositis
Nov 09, 2017
Soligenix to Present Data on Dusquetide in Combating Antibiotic-Resistant Infections at the 2nd Annual Superbugs & Superdrugs USA Conference
Sep 20, 2017
Soligenix Announces $1.5 Million NIDCR SBIR Grant Award Supporting the Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer
Sep 11, 2017
Dusquetide as a Potential Solution to Antimicrobial Resistant Bacteria to be Presented at the 2017 World Anti-Microbial Resistance Congress
Aug 11, 2017
Soligenix Announces Recent Accomplishments And Second Quarter 2017 Financial Results
Jul 27, 2017
Soligenix Initiates Pivotal Phase 3 Clinical Trial of SGX942 (Dusquetide) for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Jun 19, 2017
Complete Efficacy and Long-Term Follow-Up Safety Results from SGX942 Phase 2 Oral Mucositis Clinical Trial to be Presented at the 2017 Multinational Association for Supportive Care in Cancer Conference
Latest News
Jul 27, 2024
LuxCreo Expands Partnership with ASICS to Make Personalized Shoes Accessible to Everyone
Jul 27, 2024
Smith Foundry Shutting Down Minnesota Facility
Jul 27, 2024
Fonon Corporation Quartz Laser Welding Benefits Glass Manufacturers
Jul 27, 2024
Pioneer Power Announces Filing of Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2023
Jul 27, 2024
OKX and Manchester City Launch 'Unseen City Collectibles Quest': A Digital Treasure Hunt during...
Jul 27, 2024
Kim calls for 'people's paradise' on Korean War anniversary
Jul 27, 2024
Philippines says 'no incidents' as it resupplies hotspot reef
Jul 27, 2024
Alliance Resource Partners, L.P. Declares Quarterly Distribution of $0.70 Per Unit; Announces Robinson...
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
View All Events